Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Batalla, Albert ^a,b,c   Bhattacharyya, Sagnik ^d   Yücel, Murat ^c   Fusar Poli, Paolo ^d   Crippa, Jose Alexandre ^e,f   Nogué, Santiago ^b   Torrens, Marta ^g,h   Pujol, Jesús ⁱ   Farré, Magí ^g,h   Martin Santos, Rocio ^a,b,f  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f National Science and Technology Institute INCT for Translational Medicine   (Brazil)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h INST MUNIC D INVESTIGACIO MEDICA   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOL; DRONABINOL; TETRAHYDROCANNABINOL;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AFFECT; ARTICLE; ATTENTION; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN SIZE; CANNABIS ADDICTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DECISION MAKING; DIFFUSION TENSOR IMAGING; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CELL INHIBITION; NERVE CONDUCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PSYCHOMOTOR PERFORMANCE; RESTING REGIONAL CEREBRAL BLOOD FLOW; STRUCTURAL NEUROIMAGING; STRUCTURE ANALYSIS; SYSTEMATIC REVIEW; TASK PERFORMANCE; VERBAL MEMORY; WORKING MEMORY;

ADOLESCENT; ADULT; CANNABINOIDS; CANNABIS; CEREBELLUM; COGNITION; DATABASES, BIBLIOGRAPHIC; FEMALE; FRONTAL LOBE; HUMANS; MALE; MARIJUANA ABUSE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; TEMPORAL LOBE;

EID: 84873489002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055821     Document Type: Article

References (193)

1. European Monitoring Centre for Drugs and Drug Addiction (2011) The state of the drugs problem in Europe. EMCDDA. Available: http://www.emcdda.europa.eu/publications/annual-report/2011. Accessed 2 February 2012.
2. United Nations Office on Drugs and Crime (2011) World drug report 2011. UNODC, Vienna 2011. Available: http://www.unodc.org/unodc/en/data-and-analysis/WDR-2011.html. Accessed 2 February 2012.
3. Chen CY, O'Brien MS, Anthony JC, (2005) Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 79: 11-22.
4. Fernandez-Artamendi S, Fernandez-Hermida JR, Secades-Villa R, Garcia-Portilla P, (2011) Cannabis and mental health. Actas Esp Psiquiatr 39: 180-190.
5. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, et al. (2009) Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442-451.
6. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, et al. (2012) Induction of psychosis by {delta}9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69: 27-36.
7. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, et al. (2012) Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry Jan 31.[Epub ahead of print].
8. Hall W, Degenhardt L, (2009) Adverse health effects of non-medical cannabis use. Lancet 374: 1383-1391.
9. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319-328.
10. Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, et al. (2011) Disruption of frontal theta coherence by Delta9-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology 36: 827-836.
11. Solowij N, Battisti R, (2008) The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1: 81-98.
12. Stone JM, Bhattacharyya S, Barker GJ, McGuire PK, (2012) Substance use and regional gray matter volume in individuals at high risk of psychosis. Eur Neuropsychopharmacol 22: 114-122.
13. Stone JM, Morrison PD, Brugger S, Nottage J, Bhattacharyya S, et al. (2012) Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence. Mol Psychiatry 17: 568-569.
14. Sundram S, (2006) Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol 21: 245-254.
15. van Winkel R, (2011) Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 68: 148-157.
16. Chevaleyre V, Takahashi KA, Castillo PE, (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76.
17. Morrison PD, Murray RM, (2009) From real-world events to psychosis: the emerging neuropharmacology of delusions. Schizophr Bull 35: 668-674.
18. Belue RC, Howlett AC, Westlake TM, Hutchings DE, (1995) The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol 17: 25-30.
19. Burns HD, Van LK, Sanabria-Bohorquez S, Hamill TG, Bormans G, et al. (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad SciUSA 104: 9800-9805.
20. Gaoni Y, Mechoulam R, (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. JAm Chem Soc 93: 217-224.
21. Hoffman AF, Oz M, Yang R, Lichtman AH, Lupica CR, (2007) Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem 14: 63-74.
22. Landfield PW, Cadwallader LB, Vinsant S, (1988) Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res 443: 47-62.
23. Scallet AC, Uemura E, Andrews A, Ali SF, McMillan DE, et al. (1987) Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Res 436: 193-198.
24. Bossong MG, Niesink RJ, (2010) Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92: 370-385.
25. Adriani W, Laviola G, (2004) Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 15: 341-352.
26. Schneider M, Koch M, (2003) Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28: 1760-1769.
27. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, et al. (2008) Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 33: 1113-1126.
28. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yucel M, (2010) Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse 45: 1787-1808.
29. Martin-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, et al. (2010) Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med 40: 383-398.
30. Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P, (2009) Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 15: 2603-2614.
31. Solowij N, Pesa N, (2010) [Cognitive abnormalities and cannabis use]. Rev Bras Psiquiatr 32Suppl 1: S31-S40.
32. Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, et al. (2003) Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 69: 303-310.
33. Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, et al. (2000) Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis 19: 1-22.
34. Jager G, Ramsey NF, (2008) Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr Drug Abuse Rev 1: 114-123.
35. Crews F, He J, Hodge C, (2007) Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86: 189-199.
36. D'Souza DC, Sewell RA, Ranganathan M, (2009) Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259: 413-431.
37. Durston S, Hulshoff Pol HE, Casey BJ, Giedd JN, Buitelaar JK, et al. (2001) Anatomical MRI of the developing human brain: what have we learned? J Am Acad Child Adolesc Psychiatry 40: 1012-1020.
38. Jernigan TL, Gamst AC, (2005) Changes in volume with age--consistency and interpretation of observed effects. Neurobiol Aging 26: 1271-1274.
39. Huttenlocher PR, Dabholkar AS, (1997) Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167-178.
40. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, et al. (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 101: 8174-8179.
41. Chang L, Chronicle EP, (2007) Functional imaging studies in cannabis users. Neuroscientist 13: 422-432.
42. Crean RD, Crane NA, Mason BJ, (2011) An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5: 1-8.
43. Gonzalez R, (2007) Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev 17: 347-361.
44. Quickfall J, Crockford D, (2006) Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18: 318-332.
45. Bhattacharyya S, Sendt KV, (2012) Neuroimaging evidence for cannabinoid modulation of cognition and affect in man. Front Behav Neurosci 6: 22.
46. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, McGuire PK, (2012) Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies. Curr Pharm Des 18: 5045-5054.
47. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
48. Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, et al. (2004) Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology 29: 417-426.
49. Churchwell JC, Lopez-Larson M, Yurgelun-Todd DA, (2010) Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol 1: 225.
50. Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, et al. (2012) Neural responses associated with cue-reactivity in frequent cannabis users. Addict Biol Jan 20.[Epub ahead of print].
51. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA, (2004) Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 176: 239-247.
52. Lopez-Larson MP, Bogorodzki P, Rogowska J, McGlade E, King JB, et al. (2011) Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res 220: 164-172.
53. Murphy K, Dixon V, LaGrave K, Kaufman J, Risinger R, et al. (2006) A validation of event-related FMRI comparisons between users of cocaine, nicotine, or cannabis and control subjects. Am J Psychiatry 163: 1245-1251.
54. Prescot AP, Locatelli AE, Renshaw PF, Yurgelun-Todd DA, (2011) Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage 57: 69-75.
55. Schneider M, (2008) Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 13: 253-263.
56. Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA, (2011) Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res 191: 201-211.
57. Aasly J, Storsaeter O, Nilsen G, Smevik O, Rinck P, (1993) Minor structural brain changes in young drug abusers. A magnetic resonance study. Acta Neurol Scand 87: 210-214.
58. Amen DG, Waugh M, (1998) High resolution brain SPECT imaging of marijuana smokers with AD/HD. J Psychoactive Drugs 30: 209-214.
59. Campbell AM, Evans M, Thomson JL, Williams MJ, (1971) Cerebral atrophy in young cannabis smokers. Lancet 2: 1219-1224.
60. Co BT, Goodwin DW, Gado M, Mikhael M, Hill SY, (1977) Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography. JAMA. 237: 1229-1230.
61. Hannerz J, Hindmarsh T, (1983) Neurological and neuroradiological examination of chronic cannabis smokers. Ann Neurol 13: 207-210.
62. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR, (2004) Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci 1021: 384-390.
63. Kuehnle J, Mendelson JH, Davis KR, New PF, (1977) Computed tomographic examination of heavy marijuana smokers. JAMA 237: 1231-1232.
64. O'Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, et al. (2000) Acute marijuana effects on rCBF and cognition: a PET study. Neuroreport 11: 3835-3841.
65. Sneider JT, Pope HG Jr, Silveri MM, Simpson NS, Gruber SA, et al. (2006) Altered regional blood volume in chronic cannabis smokers. Exp Clin Psychopharmacol 14: 422-428.
66. Ward PB, Solowij N, Peters R, Otton J, Chesher G, et al. (2002) An fMRI study of regional brain volumes in long-term cannabis users. J Psychopharmacol 16(Suppl. 3).
67. Yurgelun-Todd D, Gruber SA, Hanson RA, Baird AA, Renshaw PF, et al. (1998) Residual effects of marijuana use: an fMRI study. In: Problems of drug dependence 1998: Proceedings of the 60th Annual Scientific Meeting, The College on Problems of Drug Dependence. NIDA Research Monograph. pp.78.
68. Zalesky A, Solowij N, Yucel M, Lubman DI, Takagi M, et al. (2012) Effect of long-term cannabis use on axonal fibre connectivity. Brain 135: 2245-2255.
69. Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J, (2010) The impact of early-onset cannabis use on functional brain correlates of working memory. Prog Neuropsychopharmacol Biol Psychiatry 34: 837-845.
70. Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, et al. (2011) Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Drug Alcohol Depend 114: 242-245.
71. Leroy C, Karila L, Martinot JL, Lukasiewicz M, Duchesnay E, et al. (2012) Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict Biol 17: 981-990.
72. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Pazos A, et al. (2010) Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res 1317: 297-304.
73. Parkar SR, Ramanathan S, Nair N, Batra SA, Adarkar SA, et al. (2010) Cannabis dependence: Effects of cannabis consumption on inter-regional cerebral metabolic relationships in an Indian population. Indian J Psychiatry 52: 236-242.
74. Smith AM, Longo CA, Fried PA, Hogan MJ, Cameron I, (2010) Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacology (Berl) 210: 429-438.
75. Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG, (2001) Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 107: 173-177.
76. Wiesbeck GA, Taeschner KL, (1991) A cerebral computed tomography study of patients with drug-induced psychoses. Eur Arch Psychiatry Clin Neurosci 241: 88-90.
77. Hermann D, Sartorius A, Welzel H, Walter S, Skopp G, et al. (2007) Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry 61: 1281-1289.
78. Nestor L, Roberts G, Garavan H, Hester R, (2008) Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. Neuroimage 40: 1328-1339.
79. Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, et al. (2008) Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) 196: 119-131.
80. Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J, (2010) Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology (Berl) 209: 361-374.
81. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE, (2009) Marijuana craving in the brain. Proc Natl Acad Sci USA 106: 13016-13021.
82. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE, (2010) Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology 35: 967-975.
83. Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE, (1992) Changes in middle cerebral artery velocity after marijuana. Biol Psychiatry 32: 164-169.
84. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, et al. (1991) Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose. Psychiatry Res 40: 69-78.
85. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, et al. (2009) Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res 43: 189-204.
86. Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, et al. (2009) Altered white matter microstructure in adolescent substance users. Psychiatry Res 173: 228-237.
87. Bava S, Jacobus J, Mahmood O, Yang TT, Tapert SF, (2010) Neurocognitive correlates of white matter quality in adolescent substance users. Brain Cogn 72: 347-354.
88. Cheetham A, Allen NB, Whittle S, Simmons J, Yucel M, et al. (2012) Orbitofrontal Volumes in Early Adolescence Predict Initiation of Cannabis Use: A 4-Year Longitudinal and Prospective Study. Biol Psychiatry 71: 684-692.
89. Chung T, Geier C, Luna B, Pajtek S, Terwilliger R, et al. (2011) Enhancing response inhibition by incentive: comparison of adolescents with and without substance use disorder. Drug Alcohol Depend 115: 43-50.
90. Clark DB, Chung T, Thatcher DL, Pajtek S, Long EC, (2012) Psychological dysregulation, white matter disorganization and substance use disorders in adolescence. Addiction 107: 206-214.
91. Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, et al. (2011) Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Int J Neuropsychopharmacol 1-11.
92. Cornelius JR, Aizenstein HJ, Hariri AR, (2010) Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addict Behav 35: 644-646.
93. Cowan RL, Joers JM, Dietrich MS, (2009) N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study. Pharmacol Biochem Behav 92: 105-110.
94. Dekker N, Schmitz N, Peters BD, van Amelsvoort TA, Linszen DH, et al. (2010) Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Res 181: 51-56.
95. Habets P, Marcelis M, Gronenschild E, Drukker M, van OJ, (2011) Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry 69: 487-494.
96. Ho BC, Wassink TH, Ziebell S, Andreasen NC, (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128: 66-75.
97. Jacobus J, McQueeny T, Bava S, Schweinsburg BC, Frank LR, et al. (2009) White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicol Teratol 31: 349-355.
98. Jager G, Block RI, Luijten M, Ramsey NF (2010) Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 49:: 561-72, 572.
99. James A, Hough M, James S, Winmill L, Burge L, et al. (2011) Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res 128: 91-97.
100. Kumra S, Robinson P, Tambyraja R, Jensen D, Schimunek C, et al. (2012) Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry 51: 171-180.
101. Li CS, Milivojevic V, Constable RT, Sinha R, (2005) Recent cannabis abuse decreased stress-induced BOLD signals in the frontal and cingulate cortices of cocaine dependent individuals. Psychiatry Res 140: 271-280.
102. Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF, (2007) Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatry 48: 592-600.
103. Parkar SR, Ramanathan S, Nair N, Batra SA, Adarkar SA, et al. (2011) Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian J Psychiatry 53: 13-20.
104. Peters BD, de HL, Vlieger EJ, Majoie CB, den Heeten GJ, et al. (2009) Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity? Psychopharmacol Bull 42: 75-88.
105. Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, et al. (2010) Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur Neuropsychopharmacol 20: 855-865.
106. Roberts GM, Garavan H, (2010) Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. Neuroimage 52: 429-435.
107. Safont G, Corripio I, Escarti MJ, Portella MJ, Perez V, et al. (2011) Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study. Schizophr Res 129: 169-171.
108. Schweinsburg AD, Schweinsburg BC, Cheung EH, Brown GG, Brown SA, et al. (2005) fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug Alcohol Depend 79: 201-210.
109. Solowij N, Yucel M, Respondek C, Whittle S, Lindsay E, et al. (2011) Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol Med 41: 2349-2359.
110. Takagi M, Lubman DI, Walterfang M, Barton S, Reutens D, et al. (2011) Corpus callosum size and shape alterations in adolescent inhalant users. Addict Biol Sep 29.[Epub ahead of print].
111. Tanabe J, Thompson L, Claus E, Dalwani M, Hutchison K, et al. (2007) Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum Brain Mapp 28: 1276-1286.
112. Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, et al. (2005) Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers. Synapse 57: 113-115.
113. Welch KA, McIntosh AM, Job DE, Whalley HC, Moorhead TW, et al. (2011) The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull 37: 1066-1076.
114. Welch KA, Stanfield AC, McIntosh AM, Whalley HC, Job DE, et al. (2011) Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia. Br J Psychiatry 199: 386-390.
115. Wobrock T, Sittinger H, Behrendt B, D'Amelio R, Falkai P, (2009) Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci 259: 28-36.
116. Yucel M, Zalesky A, Takagi MJ, Bora E, Fornito A, et al. (2010) White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study. J Psychiatry Neurosci 35: 409-412.
117. Barkus E, Morrison PD, Vuletic D, Dickson JC, Ell PJ, et al. (2011) Does intravenous Delta9-tetrahydrocannabinol increase dopamine release? A SPET study. J Psychopharmacol 25: 1462-1468.
118. Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, et al. (2008) Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966-973.
119. Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, et al. (2009) Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34: 759-766.
120. Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, et al. (2012) Effects of Delta9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study. J Cogn Neurosci 24: 588-599.
121. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, et al. (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66: 95-105.
122. Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, et al. (2010) Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. Int J Neuropsychopharmacol 13: 421-432.
123. Mathew RJ, Wilson WH, Tant SR, (1989) Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 79: 118-128.
124. Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE, (1992) Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 12: 750-758.
125. Mathew RJ, Wilson WH, (1993) Acute changes in cerebral blood flow after smoking marijuana. Life Sci 52: 757-767.
126. Mathew RJ, Wilson WH, Coleman RE, Turkington TG, Degrado TR, (1997) Marijuana intoxication and brain activation in marijuana smokers. Life Sci 60: 2075-2089.
127. Mathew RJ, Wilson WH, Turkington TG, Coleman RE, (1998) Cerebellar activity and disturbed time sense after THC. Brain Res 797: 183-189.
128. Mathew RJ, Wilson WH, Chiu NY, Turkington TG, Degrado TR, et al. (1999) Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 100: 67-75.
129. Mathew RJ, Wilson WH, Turkington TG, Hawk TC, Coleman RE, et al. (2002) Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Res 116: 173-185.
130. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, et al. (2002) Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 26: 802-816.
131. O'Leary DS, Block RI, Turner BM, Koeppel J, Magnotta VA, et al. (2003) Marijuana alters the human cerebellar clock. Neuroreport 14: 1145-1151.
132. O'Leary DS, Block RI, Koeppel JA, Schultz SK, Magnotta VA, et al. (2007) Effects of smoking marijuana on focal attention and brain blood flow. Hum Psychopharmacol 22: 135-148.
133. Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, et al. (2008) Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci 28: 2313-2319.
134. Pillay SS, Rogowska J, Kanayama G, Jon DI, Gruber S, et al. (2004) Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend 76: 261-271.
135. Rabinak CA, Sripada CS, Angstadt M, de WH, Phan KL, (2012) Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J Neural Transm 119: 701-707.
136. Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM, (2009) Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage 48: 186-190.
137. Stokes PR, Egerton A, Watson B, Reid A, Breen G, et al. (2010) Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage 52: 1521-1527.
138. van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, et al. (2011) Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. Int J Neuropsychopharmacol 14: 1377-1388.
139. van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, et al. (2012) Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology (Berl) 219: 981-990.
140. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, et al. (1996) Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res 67: 29-38.
141. Winton-Brown TT, Allen P, Bhattacharyya S, Borgwardt SJ, Fusar-Poli P, et al. (2011) Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology 36: 1340-1348.
142. Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, et al. (2011) Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 42: 1778-1780.
143. Block RI, O'Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, et al. (2000) Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 11: 491-496.
144. Arnone D, Barrick TR, Chengappa S, Mackay CE, Clark CA, et al. (2008) Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage 41: 1067-1074.
145. Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, et al. (2011) Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res 45: 1055-1066.
146. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, et al. (2012) Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 59: 3845-3851.
147. Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D, (2011) Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol 19: 231-242.
148. Matochik JA, Eldreth DA, Cadet JL, Bolla KI, (2005) Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 77: 23-30.
149. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, et al. (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65: 694-701.
150. DeLisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K, et al. (2006) A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct J 3: 17.
151. Gruber SA, Yurgelun-Todd DA, (2005) Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res 23: 107-118.
152. Jager G, van Hell HH, De Win MM, Kahn RS, van den Brink W, et al. (2007) Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychopharmacol 17: 289-297.
153. Tzilos GK, Cintron CB, Wood JB, Simpson NS, Young AD, et al. (2005) Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict 14: 64-72.
154. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, et al. (2009) Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol 14: 457-468.
155. Medina KL, Nagel BJ, Tapert SF, (2010) Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res 182: 152-159.
156. McQueeny T, Padula CB, Price J, Medina KL, Logan P, et al. (2011) Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res 224: 128-134.
157. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Ponto LL, et al. (2000) Cerebellar hypoactivity in frequent marijuana users. Neuroreport 11: 749-753.
158. Lundqvist T, Jonsson S, Warkentin S, (2001) Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol Teratol 23: 437-443.
159. Sevy S, Smith GS, Ma Y, Dhawan V, Chaly T, et al. (2008) Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) 197: 549-556.
160. Stokes PR, Egerton A, Watson B, Reid A, Lappin J, et al. (2012) History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol 26: 144-149.
161. Albrecht DS, Skosnik PD, Vollmer JM, Brumbaugh MS, Perry KM, et al. (2012) Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Depend Aug 18.[Epub ahead of print].
162. Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, et al. (2012) Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry 71: 677-683.
163. Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, et al. (2012) Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Mol Psychiatry 17: 642-649.
164. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, et al. (2002) Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav 72: 237-250.
165. Bolla KI, Eldreth DA, Matochik JA, Cadet JL, (2005) Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26: 480-492.
166. Eldreth DA, Matochik JA, Cadet JL, Bolla KI, (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 23: 914-920.
167. Vaidya JG, Block RI, O'Leary DS, Ponto LB, Ghoneim MM, et al. (2012) Effects of chronic marijuana use on brain activity during monetary decision-making. Neuropsychopharmacology 37: 618-629.
168. Abdullaev Y, Posner MI, Nunnally R, Dishion TJ, (2010) Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav Brain Res 215: 45-57.
169. Chang L, Yakupov R, Cloak C, Ernst T, (2006) Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129: 1096-1112.
170. Gruber SA, Rogowska J, Yurgelun-Todd DA, (2009) Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend 105: 139-153.
171. Harding IH, Solowij N, Harrison BJ, Takagi M, Lorenzetti V, et al. (2012) Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology 37: 1923-1933.
172. Hester R, Nestor L, Garavan H, (2009) Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34: 2450-2458.
173. Jager G, Kahn RS, van den Brink W, van Ree JM, Ramsey NF, (2006) Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology (Berl) 185: 358-368.
174. King GR, Ernst T, Deng W, Stenger A, Gonzales RM, et al. (2011) Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci 31: 17923-17931.
175. Nestor L, Hester R, Garavan H, (2010) Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. Neuroimage 49: 1133-1143.
176. van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, et al. (2010) Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol 20: 153-163.
177. Wesley MJ, Hanlon CA, Porrino LJ, (2011) Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res 191: 51-59.
178. Bechara A, Tranel D, Damasio H, (2000) Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 123 (Pt 11): 2189-2202.
179. Padula CB, Schweinsburg AD, Tapert SF, (2007) Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol Addict Behav 21: 478-487.
180. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, et al. (2008) Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res 163: 40-51.
181. Schweinsburg AD, Schweinsburg BC, Medina KL, McQueeny T, Brown SA, et al. (2010) The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs 42: 401-412.
182. Schweinsburg AD, Schweinsburg BC, Nagel BJ, Eyler LT, Tapert SF, (2011) Neural correlates of verbal learning in adolescent alcohol and marijuana users. Addiction 106: 564-573.
183. Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, et al. (2007) Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl) 194: 173-183.
184. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
185. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, et al. (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287: 1123-1131.
186. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, et al. (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389.
187. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL, (2002) Dose-related neurocognitive effects of marijuana use. Neurology 59: 1337-1343.
188. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, et al. (2012) Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A Aug 27. [Epub ahead of print].
189. Licata SC, Renshaw PF, (2010) Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci 1187: 148-171.
190. Okuda M, Hasin DS, Olfson M, Khan SS, Nunes EV, et al. (2010) Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend 111: 177-181.
191. Glover GH, Mueller BA, Turner JA, van Erp TG, Liu TT, et al. (2012) Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging 36: 39-54.
192. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, et al. (2010) Toward discovery science of human brain function. Proc Natl Acad Sci USA 107: 4734-4739.
193. Milham MP, (2012) Open neuroscience solutions for the connectome-wide association era. Neuron 73: 214-218.